What drove the 13.64% fall in 9G2.SI stock?

The drop on 16 Jan 2026 reflected heavy volume **9,129,900**, profit-taking after recent gains and limited company news. Thin liquidity in the Medical - Care Facilities sector amplified the move.

What is Meyka AI's price forecast for 9G2.SI stock?

Meyka AI's model projects **S$0.06** monthly and **S$0.08005** in 12 months, implying roughly **40.45%** upside versus the current **S$0.057**. Forecasts are model-based and not guarantees.

How does valuation look for 9G2.SI stock?

Valuation shows EPS **-0.03**, PE roughly **-1.97**, PB **1.13**, and enterprise concerns from a low current ratio **0.31**. These metrics reflect a loss-making small-cap with balance sheet constraints.

What short-term levels should traders watch for 9G2.SI stock?

Traders should watch immediate support at **S$0.055** and resistance at **S$0.060–S$0.063**. A sustained break above **S$0.06312** (50-day MA) would lessen short-term downside risk.

SG Stocks

Down 13.64%: 9G2.SI Singapore Inst. of Adv. Medicine (SES) Jan 2026: 0.08 SGD

ByDanny Kontos January 16, 2026January 16, 2026

Singapore Institute of Advanced Medicine Holdings Ltd. (9G2.SI stock) fell 13.64% to S$0.057 as the SES session closed on 16 Jan 2026. Trading showed heavy participation with 9,129,900 shares changing hands, about 2.02x average volume. The move put the counter below its 50-day average S$0.06312 while still above the 200-day S$0.03999, signalling short-term weakness inside a multi-month recovery. We review drivers, valuation, technicals and Meyka AI model forecasts for near-term price targets and risk points